| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.001 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |